Sabra Health Care REIT Inc <SBRA.O>: Scotiabank raises target price to $20 from $19
SBRA•Related News
Graham death, McConnell absence hang over U.S. Senate as Congress returns
SPY•
Ocugen signs term sheet with Roots Pharmaceutical to license OCU400 in Middle East, North Africa
OCGN•
Delek US Holdings Inc <DK.N>: Raymond James Raises Target Price to $70 From $60
DK•
Ocugen rises on Mideast licensing deal for experimental blindness gene therapy
OCGN•
A2Z Cust2Mate appoints Gadi Levin as CFO effective immediately
AZ•